A to Z subjects
Find stories by subject. Use the A-Z options to view other subjects.
O
- obesity
- obicetrapib
- obinutuzumab
- Ocaliva
- Ocrevus (ocrelizumab)
- octreotide
- Ocugen
- Oczyesa
- oedema
- oesophageal cancer
- oesophageal squamous cell carcinoma
- Ofev
- Office of the Assistant Secretary for Preparedness and Response (ASPR)
- Ofichem
- Ogsiveo (nirogacestat)
- Ohtuvayre (ensifentrine)
- olaparib
- oligonucleotide
- Olivér Várhelyi (European Commission)
- Olivier Negre (Smart Immune)
- OLUMIANT® (baricitinib)
- Omega Therapeutics
- Omisirge (omidubicel-onlv)
- Omvoh
- Oncology
- Opdivo
- Opdivo (nivolumab)
- Ophelia Chan
- oral drugs
- Oral therapeutic candidate
- Orano med
- Orbital Therapeutics
- orforglipron
- Orhan Caglayan
- Orion Corporation
- Orphan Drugs
- Osaka Metropolitan University
- osteoporosis
- OTX-201
- Ovarian Cancer
- oveporexton
- Ozempic (semaglutide)
- ozureprubart


